Carbapenems: Difference between revisions
Mrosen5506 (talk | contribs) (→Types) |
Elcatracho (talk | contribs) |
||
| (One intermediate revision by the same user not shown) | |||
| Line 3: | Line 3: | ||
#[[Doripenem]] | #[[Doripenem]] | ||
#[[Imipenem]] | #[[Imipenem]] | ||
#[[Meropenem]] | #[[Meropenem]] | ||
#[[Meropenem-vaborbactam]]<br /> | |||
[[Meropenem-vaborbactam]] | |||
==Indications== | ==Indications== | ||
*Cephalosporin-resistant nosocomial bacteria | *Cephalosporin-resistant nosocomial bacteria | ||
*Empirical treatment of serious infections in patients who recently received other | *Empirical treatment of serious infections in patients who recently received other beta-lactams | ||
{{Template:Clinically Utilized Antibiotics}} | {{Template:Clinically Utilized Antibiotics}} | ||
Latest revision as of 05:14, 4 January 2022
Types
Indications
- Cephalosporin-resistant nosocomial bacteria
- Empirical treatment of serious infections in patients who recently received other beta-lactams
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
See Also
References
Goodman & Gilman's Pharmacology